{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T19:22:50Z","timestamp":1748200970079},"reference-count":30,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.3892\/ol.2015.3119","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T08:42:32Z","timestamp":1429087352000},"page":"2633-2638","source":"Crossref","is-referenced-by-count":6,"title":["Clinical significance of BRAF V600E mutation in 154 patients with thyroid nodules"],"prefix":"10.3892","volume":"9","author":[{"given":"LINGYING","family":"YU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LIZHEN","family":"MA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"QIAOFENG","family":"TU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YI","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUEMING","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAOJUN","family":"YU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHAOYU","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,4,15]]},"reference":[{"key":"key20180108103701_b1-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","article-title":"Increasing incidence of thyroid cancer in the United States","volume":"295","author":"Davies","year":"2006","journal-title":"JAMA"},{"key":"key20180108103701_b2-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.6004\/jnccn.2010.0093","article-title":"Thyroid carcinoma","volume":"8","author":"Tuttle","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"key20180108103701_b3-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1089\/thy.2012.0532","article-title":"Thyroid cancer incidence patterns in Sao Paulo, Brazil and the US SEER Program","volume":"23","author":"Veiga","year":"2013","journal-title":"Thyroid"},{"key":"key20180108103701_b4-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1726-4901(10)70025-3","article-title":"BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications","volume":"73","author":"Tang","year":"2010","journal-title":"J Chin Med Assoc"},{"key":"key20180108103701_b5-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1158\/0008-5472.CAN-06-0739","article-title":"Conditional activation of RET\/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling","volume":"66","author":"Mesa","year":"2006","journal-title":"Cancer Res"},{"key":"key20180108103701_b6-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1677\/ERC-08-0081","article-title":"Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET\/PTC rearrangement: relationship with clinico-pathological features","volume":"16","author":"Durand","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"key20180108103701_b7-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1089\/thy.2010.1646","article-title":"Genetic alterations in the phosphatidylinositol-3 kinase\/Akt pathway in thyroid cancer","volume":"20","author":"Xing","year":"2010","journal-title":"Thyroid"},{"key":"key20180108103701_b8-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00423-012-1021-x","article-title":"Coexistence of papillary thyroid cancer with Hashimoto thyroiditis","volume":"398","author":"Konturek","year":"2013","journal-title":"Langenbecks Arch Surg"},{"key":"key20180108103701_b9-ol-0-0-3119","first-page":"599","volume-title":"Diagnostic Histopathology of Tumors","author":"Zhou","year":"2001","edition":"1st"},{"key":"key20180108103701_b10-ol-0-0-3119","first-page":"715","volume-title":"Endocrinology","author":"Liao","year":"2001","edition":"1st"},{"key":"key20180108103701_b11-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/jamaoto.2013.4501","article-title":"Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience","volume":"139","author":"Gouveia","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"key20180108103701_b12-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/lary.23838","article-title":"Diagnosis and management of differentiated thyroid cancer using molecular biology","volume":"123","author":"Witt","year":"2013","journal-title":"Laryngoscope"},{"key":"key20180108103701_b13-ol-0-0-3119","first-page":"10071013","article-title":"Diagnostic value of TPO, CK-19, Gal-3 and HBME-1 in fine needle aspiration cytological specimens for thyroid carcinoma with Hashimoto's disease","volume":"32","author":"Yu","year":"2010","journal-title":"Zhejiang Medical"},{"key":"key20180108103701_b14-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.humpath.2005.04.011","article-title":"A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma","volume":"36","author":"Trovisco","year":"2005","journal-title":"Hum Pathol"},{"key":"key20180108103701_b15-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/PAS.0b013e31802f5404","article-title":"BRAF in papillary thyroid carcinoma of ovary (struma ovarii)","volume":"31","author":"Schmidt","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"key20180108103701_b16-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1210\/jc.2007-1179","article-title":"Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma","volume":"92","author":"Lupi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108103701_b17-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1210\/jc.2007-0970","article-title":"Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: cytogenetic and molecular analysis of 62 cases and correlation with histological findings","volume":"93","author":"Frau","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108103701_b18-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1089\/thy.2009.0458","article-title":"Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer","volume":"20","author":"Wolff","year":"2010","journal-title":"Thyroid"},{"key":"key20180108103701_b19-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1089\/thy.2011.0120","article-title":"BRAF (K601E) mutation in a patient with a follicular thyroid carcinoma","volume":"21","author":"Pennelli","year":"2011","journal-title":"Thyroid"},{"key":"key20180108103701_b20-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/cncy.21229","article-title":"BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular and pathologic characteristics of papillary thyroid carcinoma","volume":"121","author":"Ohori","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"key20180108103701_b21-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1897-4287-10-10","article-title":"BRAF mutations in thyroid tumors from an ethnically diverse group","volume":"10","author":"Schulten","year":"2012","journal-title":"Hered Cancer Clin Pract"},{"key":"key20180108103701_b22-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12022-013-9244-0","article-title":"BRAF and RAS mutations in follicular variants of papillary thyroid carcinoma","volume":"24","author":"Park","year":"2013","journal-title":"Endocr Pathol"},{"key":"key20180108103701_b23-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4132\/KoreanJPathol.2013.47.3.293","article-title":"A case of multifocal papillary thyroid carcinoma consisting of one encapsulated follicular variant with BRAF K601E mutation and three conventional types with BRAF V600E mutation","volume":"47","author":"Kim","year":"2013","journal-title":"Korean J Pathol"},{"key":"key20180108103701_b24-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1089\/thy.2013.0403","article-title":"Prevalence, tumorigenic role and biochemical implications of rare BRAF alterations","volume":"24","author":"Barollo","year":"2014","journal-title":"Thyroid"},{"key":"key20180108103701_b25-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00428-013-1521-2","article-title":"Prognostic biomarkers in thyroid cancer","volume":"464","author":"Soares","year":"2014","journal-title":"Virchows Archiv"},{"key":"key20180108103701_b26-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1530\/EJE-07-0896","article-title":"Thyroid papillary microcarcinoma: a descriptive and meta-analysis study","volume":"159","author":"Roti","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key20180108103701_b27-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1245\/s10434-008-0233-3","article-title":"Analysis of differential BRAF (V600E) mutational status in high aggressive papillary thyroid microcarcinoma","volume":"16","author":"Lee","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"key20180108103701_b28-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/modpathol.2012.152","article-title":"BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation","volume":"26","author":"Virk","year":"2013","journal-title":"Mod Pathol"},{"key":"key20180108103701_b29-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4174\/jkss.2013.85.1.15","article-title":"Clinical implications of preoperative thyrotropin serum concentrations in patients who underwent thyroidectomy for nonfunctioning nodule(s)","volume":"85","author":"Kim","year":"2013","journal-title":"J Korean Surg Soc"},{"key":"key20180108103701_b30-ol-0-0-3119","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/thy.2008.0144","article-title":"Clinical and pathological features and the BRAF (V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis","volume":"19","author":"Kim","year":"2009","journal-title":"Thyroid"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.3119\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T08:38:35Z","timestamp":1515400715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.3119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,15]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,4,15]]},"published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.3892\/ol.2015.3119"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.3119","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,15]]}}}